Phone: 734-615-9635|Email: vbidcenter@umich.edu
FacebookXYouTubeLinkedIn

Virtual V-BID Summit 2023: Accelerating Health Equity

VIRTUAL V-BID SUMMIT 2023

Accelerating Health Equity

On March 8th, 2023, a broad range of health care stakeholders addressed strategies to accelerate health equity, implications of overturning the ACA preventive care mandate, opportunities and challenges of reducing low-value care, and advances in policies to enhance affordability and reduce medical debt.

Their diverse expertise drove discussion about improved quality, enhanced patient experience, and cost-containment. 

Recordings of each panel can be viewed below!

VIRTUAL SUMMIT AGENDA

Recordings of each panel can be viewed below.

Panelists:

  • Grace Arnold, National Association of Insurance Commissioners
  • Joneigh Khaldun, CVS Health
  • Christen Linke Young, White House Domestic Policy Council

Panelists:

  • Mark Friedberg, Blue Cross Blue Shield of Massachusetts
  • Annette James, American Academy of Actuaries
  • Mila Kofman, Washington DC Health Benefit Exchange

Panelists:

  • Jalpa Doshi, University of Pennsylvania
  • Amy Niles, The Patient Access Network Foundation (PAN)
  • John O’Brien, National Pharmaceutical Council (NPC)

Panelists:

  • Jennifer Bright, Innovation and Value Initiative (IVI)
  • Nelly Ganesan, Morgan Health
  • Charlene Son Rigby, RareX
  • Michael Chernew, Harvard Medical School

Welcome

A. Mark Fendrick Headshot

Mark Fendrick

Director
V-BID Center

Moderator

Cliff Goodman Headshot

Cliff Goodman

Senior Vice President
The Lewin Group

Closing remarks

Harvard Health Care Policy 8_31_06 Eighteen (18) Month Non-exclusive use for HHCP's internal publications, Web-site use and gifts only Not for: Other Harvard Dept's, institiutions, organizations, indiviuals, media, etc. without written permission of Joshua Touster

Michael Chernew

Director
Harvard Medical School

SESSION 1 | 12:15-1:00 PM ET

ACCELERATING EQUITY - KEYNOTE PANEL

Session 1 | Read AJMC Article

SESSION 2 | 1:00-1:45 PM ET

EQUITY IMPLICATIONS IN HEALTH PLAN BENEFIT DESIGN

Session 2 | Read AJMC Article

SESSION 3 | 2:00-2:45 PM ET

ADVANCING PHARMACOEQUITY AND ENHANCING ACCESS
TO ESSENTIAL MEDICATIONS

Session 3 | Read AJMC Article

SESSION 4 | 2:45-3:30 PM ET

INCORPORATING EQUITY INTO
THE DETERMINATION OF VALUE

Sponsorship Opportunities

734-615-9635 | 2800 Plymouth Road, Building 16, Floor 4, Ann Arbor, MI 48109-2800

A. MARK FENDRICK

A. Mark Fendrick, M.D. is a Professor of Internal Medicine in the School of Medicine and a Professor of Health Management and Policy in the School of Public Health at the University of Michigan. 

Dr. Fendrick conceptualized and coined the term Value-Based Insurance Design (V-BID) and currently directs the V-BID Center at the University of Michigan, the leading advocate for development, implementation, and evaluation of innovative health benefit plans.  His research focuses on how clinician payment and consumer engagement initiatives impact access to care, quality of care, and health care costs.

Dr. Fendrick has authored over 250 articles and book chapters and has received numerous awards for the creation and implementation of value-based insurance design.  His perspective and understanding of clinical and economic issues have fostered collaborations with numerous government agencies, health plans, professional societies, and health care companies.

CLIFF GOODMAN

Clifford Goodman is a Senior Vice President at The Lewin Group, a health care policy consulting firm based in Falls Church, Virginia.  Dr. Goodman has 30 years of experience in such areas as health technology assessment, evidence-based health care, comparative effectiveness research, and payment.  He directs studies and projects for an international range of government agencies; pharmaceutical, biotechnology, and medical device companies; health care provider institutions; and professional, industry, and patient advocacy groups. 

Dr. Goodman is an internationally recognized health policy issues moderator and facilitator of expert panels, health industry advisory boards, and workshops.  Dr. Goodman served as Chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDPAC, 2009-12) for the US Centers for Medicare and Medicaid Services.  He served as President of the professional society Health Technology Assessment international (HTAi, 2001-13).  He received a Ph.D. from The Wharton School of the University of Pennsylvania, a Master of Science from The Georgia Institute of Technology, and a Bachelor of Arts from Cornell University.

MICHAEL CHERNEW

Michael Chernew, PhD, is the Leonard D. Schaeffer Professor of Health Care Policy and Director of the Healthcare Markets and Regulation Lab at Harvard Medical School. His research focuses on improving the healthcare system through improvements to benefit designs, payment models, and regulation of both private and public health care markets, including the Medicare Advantage program. Michael is Chair of the Medicare Payment Advisory Commission (MedPAC) and has served on several advisory panels for CMS. He is a member of the Congressional Budget Office’s Panel of Health Advisors and the Massachusetts Health Connector Board. Michael holds a PhD in economics from Stanford University and has received multiple awards for his work in healthcare policy.
Go to Top